- Research Article
39- 10.1016/j.clinthera.2010.04.013
Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: A phase III, open-label, international multicenter study
- Apr 01, 2010
- Clinical Therapeutics
- Michael Marberger + 7 more +7
